-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS Biotech signs USD 6 million promissory note financing with YA II PN

PUBT·05/01/2026 16:26:52
Listen to the news
PDS Biotech signs USD 6 million promissory note financing with YA II PN
  • PDS Biotech signed securities purchase agreement with YA II PN on April 30, 2026 for USD 6 million promissory note financing.
  • Note carries 10% annual interest, matures 12 months after closing, expected to close around June 12, 2026.
  • Investor also to receive warrant to buy 2,158,274 shares at USD 1.18 per share, exercisable starting six months after closing.
  • Cash proceeds from company at-the-market equity sales after closing must be applied toward scheduled note amortization, subject to specified retention limits.
  • PDS Biotech issued redemption notices to repay outstanding senior secured convertible debentures for cash at 103% of principal on June 12, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PDS Biotechnology Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-018464), on May 01, 2026, and is solely responsible for the information contained therein.